Ex-Sandoz chief joins Leukocare

Company
Leukocare AG
Appointee name
Andreas Rummelt
Country

Germany

Andreas Rummelt, formerly chief executive of Sandoz, the generics division of Novartis, has joined the supervisory board of Leukocare AG, a privately held company in Martinsried, Germany that provides formulation services to the biopharmaceutical industry. Dr Rummelt is currently managing partner of the consulting firm InterPharmaLink in Basel, Switzerland and is a board member of several life science companies. His appointment was made on 12 July at Leukocare’s annual general meeting.

Copyright 2016 Evernow Publishing Ltd